U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) as the First Medication for Add-On Treatment of Major Depressive Diso... (Berman RM Marcus RN Swanink R et al. The...)

U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) as the First Medication for Add-On Treatment of Major Depressive Disorder (MDD)

Date:11/20/2007

Berman RM, Marcus RN, Swanink R, et al. The Efficacy and Safety of

Aripiprazole as Adjunctive Therapy in Major Depressive Disorder: A

Multicenter, Randomized, Double-Blind, Placebo-Controlled Study. J

Clin Psychiatry. 2007;68:843-853.

(4) National Alliance on Mental Illness (NAMI) Web site. About Mental

Illness: Major Depression. 2006. Accessed August 2007.

(5) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition,

Text revision. Washington DC, American Psychiatric Association, 2000.

(6) Kessler RC, Chiu WT, Demler OD, Walters EE. Prevalence, severity, and

comorbidity of 12-month DSM-IV disorders in the national comorbidity

survey replication. Arch Gen Psychiatry. 2005;62:617-627.

(7) Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE.

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV

Disorders in the National Comorbidity Survey Replication. Arch Gen

Psychiatry. 2005;62:593-602.

(8) Michaud CM, McKenna MT, Begg S, et al. The burden of disease and

injury in the United States 1996. Population Health Metrics.

2006;4:11.

(9) Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of

depression in the United States: How did it change between 1990 and

2000? J Clin Psychiatry. 2003;64(12):1465-1475.

(10) IMS Auditrac NGPS: ABILIFY total monthly retail prescriptions: Data

accessed July 2007.

Post Your Comments:

U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) as the First Medication for Add-On Treatment of Major Depressive Diso...(Berman RM Marcus RN Swanink R et al. The...)